Hyundai Motor India Limited has announced an earnings conference call to discuss its Q3 & 9M FY26 financial results. The company has formally notified the National Stock Exchange of India and BSE Limited about this scheduled investor meeting, in compliance with SEBI listing regulations.

Conference Call Details

The earnings call is scheduled for February 02, 2026, and will provide investors and analysts with insights into the company's quarterly and nine-month performance. The management will conduct a live conference call followed by an interactive question-and-answer session.

International Participation

To accommodate global investors, the company has provided international timing references for the conference call:

Regulatory Compliance and Information Sharing

The notification to stock exchanges was made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Company Secretary and Compliance Officer Pradeep Chugh signed the formal communication on January 28, 2026.

The company has emphasized that all discussions during the conference call will be based on publicly available information. No Unpublished Price Sensitive Information (UPSI) will be shared during the meeting, ensuring compliance with regulatory guidelines.

Presentation and Documentation

The investor presentation to be discussed during the earnings call will be submitted to stock exchanges before the call commences. Additionally, the presentation will be made available on the company's official website under the investor relations section. Participants are advised to dial-in at least 5-10 minutes prior to the scheduled time to ensure proper connection to the call.

Hyundai Motor India shares have declined 20% from their record high touched in September, as investors grapple with mixed signals on demand outlook and concerns over margin pressure from the company's newest manufacturing facility. While the automaker continues to benefit from export growth and product mix improvements, analysts highlight limited gains from recent GST rate cuts and near-term operational headwinds.

Limited GST Benefits Impact Growth Prospects

The recent GST rate reduction has provided minimal support to Hyundai's sales performance, according to analyst assessments. InCred Equities notes that benefits from the lower 18% GST rate are restricted to just 30% of the company's net sales. This limited exposure stems from strong growth over the past three years in exports, parts and services, and large SUVs, which has reduced Hyundai's dependence on products covered under the new GST framework.

With demand sensitivity expected to be higher in low-priced compact cars, analysts believe Hyundai's sales benefit from the GST rate cut will be limited compared with competitors such as Maruti Suzuki and Tata Motors. This dynamic could extend the underperformance of Hyundai's domestic volume growth versus market leaders seen in recent months.

December Sales Show Mixed Performance

Hyundai Motor India Limited reported total sales of 58,702 units in December 2025, reflecting a 6.6% year-on-year increase compared to December 2024. However, the performance marked a sequential slowdown from the 66,840 units sold in November 2025.

Despite the sequential decline, exports continued to provide strong support, rising 26.5% year-on-year in December, broadly in line with the 26.9% year-on-year growth recorded in November. In November, Hyundai's total sales had grown 9.1% year-on-year, aided by a 4.3% increase in domestic volumes.

Pune Plant Expansion Creates Near-Term Margin Pressure

The recently commissioned Pune plant is expected to drive nearly 30% capacity expansion for Hyundai. InCred Equities expects the facility to initially produce refreshed versions of the Venue and Exter models, while a new compact car launch is scheduled for FY27F. An India-dedicated electric vehicle planned for CY27F will also be closely monitored by investors.

However, analysts warn that high overheads from the new plant may weigh on EBITDA margins until capacity utilization improves. Citi notes that near-term cost pressures could emerge from the Pune plant start-up, which may add 20% to 25% in overheads.

Analyst Outlook and Ratings

Despite near-term challenges, brokerage firms maintain varied perspectives on Hyundai's prospects:

Nuvama Institutional Equities expects Q3 revenue to grow in the mid-single digits, supported by better product mix, higher exports, and INR depreciation on a year-on-year basis. The brokerage also anticipates EBITDA margin expansion driven by localization initiatives and lower discounts, though demand outlook and new product timelines remain key monitoring points.

Morgan Stanley has cautioned about potential margin pressure in the second half due to facility ramp-up and higher depreciation, while maintaining expectations for margin recovery from FY27 as volumes increase. After Q2 results, the international brokerage trimmed volume and EBITDA margin estimates by 1% to 3% and 30 to 40 basis points respectively.